Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life
- Resource Type
- Article
- Source
- In
Multiple Sclerosis and Related Disorders February 2024 82 - Subject
- Language
- ISSN
- 2211-0348